Cargando…
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy
Anti-PD-1 therapy is used as a front-line treatment for many cancers, but mechanistic insight into this therapy resistance is still lacking. Here we generate a humanized (Hu)-mouse melanoma model by injecting fetal liver-derived CD34(+) cells and implanting autologous thymus in immune-deficient NOD-...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804257/ https://www.ncbi.nlm.nih.gov/pubmed/33436641 http://dx.doi.org/10.1038/s41467-020-20600-7 |